Curio Digital Therapeutics Applauded by Frost & Sullivan for Enhancing Women’s Maternal Mental Healthcare with its MamaLift and MamaLift Plus Solutions
Frost & Sullivan
OCTOBER 18, 2024
SAN ANTONIO, TX. – October 18, 2024 – Frost & Sullivan assessed the women’s health digital therapeutics industry, and based on its analysis results, recognizes Curio Digital Therapeutics with the 2024 Global New Product Innovation Award. The company is a leading developer of innovative digital health solutions focused on women’s mental health. It utilizes a predictive algorithm for early identification and triage of common mental health disorders affecting women, turning data into actionable
Let's personalize your content